Prevention of bone loss in cardiac transplant recipients. A comparison of biphosphonates and vitamin D

Transplantation

Volumn 61, Issue 10, 1996, Pages 1495-1499

  Van Cleemput, Johan ^a   Daenen, Wim ^a   Geusens, Piet ^a   Dequeker, Jan ^a   Van De Werf, Frans ^a   Vanhaecke, Johan ^a,b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALFACALCIDOL; CACIT; CALCIUM CARBONATE; ETIDRONIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BONE ATROPHY; BONE DENSITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FEMUR NECK FRACTURE; HEART TRANSPLANTATION; HUMAN; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPINE RADIOGRAPHY;

CALCIUM; ETIDRONIC ACID; HEART TRANSPLANTATION; HUMANS; HYDROXYCHOLECALCIFEROLS; MIDDLE AGED; OSTEOPOROSIS; TIME FACTORS; VITAMIN D;

EID: 0030015066     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199605270-00015     Document Type: Article

References (20)

1. Rich GM, Mudge GH, Laffel GL, Leboff MS. Cyclosporin A and prednisone-associated osteoporosis in heart transplant recipients. J Heart Lung Transplant 1992; 11: 950.
2. Shane E, Del Rivas M, Silverberg SJ, et al. Osteoporosis after cardiac transplantation. Am J Med 1993; 94: 257.
3. Muchmore JS, Cooper DKC, Ye Y, Schlegel V, Pribil A, Zuhoi N. Prevention of loss of vertebral bone density in heart transplant patients. J Heart Lung Transplant 1992; 11: 959.
4. Van Cleemput J, Daenen W, Nijs J, Geussens P, Dequeker J, Vanhaecke J. Timing and quantification of bone loss in cardiac transplant recipients. Transplant Int 1995; 8: 196.
5. Sambrook PN, Kelly PJ, Keogh AM, et al. Bone loss after cardiac transplantation: a prospective study. J Heart Lung Transplant 1994; 13: 116.
6. Katz IA, Epstein S. Perspectives. Posttransplantation bone disease. J Bone Min Res 1992; 7: 123.
7. Reid IR. Pathogenesis and treatment of steroid osteoporosis. Clin Endocrinol 1989; 30: 83.
8. Sambrook P, Birmingham J, Kelly P, et al. Prevention of corticosteroid osteoporosis: a comparison of calcium, calcitriol and calcitonin. N Engl J Med 1993; 328: 1747.
9. Hahn TJ, Halstead LR, Teitelbaum SL, Hahn BH. Altered mineral metabolism in glucocoriticoid induced osteopoenia: effect of 25-hydroxy vitamin D administration. J Clin Invest 1979; 64: 655.
10. Kelly PJ, Sambrook PN, Eismann JA. Potential protection by cyclosporin against glucocorticoid effects on bone. Lancet 1989; 2: 1388.
11. Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S. Cyclosporin A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. Endocrinology 1988; 123: 2571.
12. Movsowitz C, Epstein S, Ismail F, Fallon M, Thomas S. Cyclosporin A in the oophorectomized rat: unexpected severe bone resorption. J Bone Miner Res 1989; 4: 393.
13. Schlosberg M, Movsowitz C, Epstein S, Ismail F, Fallon M, Thomas S. The effect of cyclosporin A administration and its withdrawal on bone mineral metabolism in the rat. Endocrinology 1989; 124: 2179.
14. Movsowitz C, Epstein S, Schlosberg M, Fallon M, Ismail F, Thomas S. The biphosphonate 2PEBP inhibits cyclosporine A induced high turnover osteopenia in the rat. J Lab Clin Med 1990; 115: 62.
15. Stein B, Takizawa M, Katz I, Joffe I, Berlin J, Fallon M. Salmon calcitonin prevents cyclosporin A induced high turnover bone loss. Endocrinology 1991; 299: 92.
16. Bouillon R, Coopmans W, DeGroote DEH, Radoux D, Eliard PH. Immunoradiometric assay of parathyrin with polyclonal and monoclonal region-specific antibodies. Clin Chem 1990; 36: 271.
17. Bouillon R, Van Kerckhove P, De Moor P. Measurement of 25-hydroxyvitamin D3 in serum. Clin Chem 1976; 22: 364.
18. Bouillon R, Vanderschueren D, Van Herck E, et al. Homologous radioimmunoassay of human osteocalcin. Clin Chem 1992; 38: 2055.
19. Mulder H, Inelder HAA. Effect of cyclical etidoronate regimen on prophylaxis of bone loss of glucocorticoid therapy in postmenopausal women. Bone Miner 1992; 17: 168.
20. Reid IR, King AR, Alexander CJ, Ibbertson HK. Prevention of steroid induced osteoporosis with (3-amino-1-hydroxy-propylidene)-1,1-biphosphonate (APD). Lancet 1988; 1: 143.